Market News AIOpen the app

JPMorgan raised its target price for Johnson & Johnson to $300, up from $285.

OpinionRead the original at marketscreener.com
Good for JNJ

JPMorgan raised its share target from $285 to $300, showing a more favorable view of Johnson & Johnson shares. The report offers no new company results, so the support comes from the analyst’s opinion alone.

JNJ · Johnson & Johnson

AI read · Good for JNJ

The AI's read

A higher target suggests JPMorgan sees more room for Johnson & Johnson shares to rise. The report gives no new sales, profit, or product information, so the support comes from the analyst’s view alone.

Get alerts for JNJ

Follow Johnson & Johnson (JNJ) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for JNJ
Free on the App Store and Google Play, or on the web.